Disease burden in primary sclerosing cholangitis in the Netherlands:A long-term follow-up study
Background & Aims: Primary sclerosing cholangitis (PSC) is a progressive, cholestatic liver disease which greatly impacts the lives of individuals. Burden of disease due to shortened life expectancy and impaired quality of life is ill-described. The aim of this study was to assess long-term disease burden in a large population-based registry with regard to survival, clinical course, quality adjusted life years (QALYs), medical consumption and work productivity loss. Methods: All PSC patients living in a geographically defined area covering ~50% of the Netherlands were included, together wi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2023 |
Reihe/Periodikum: | EpiPSC2 Study Group , van Munster , K N , Mol , B , Goet , J C , van Munster , S N , Weersma , R K , de Vries , A C , van der Meer , A J , Inderson , A , Drenth , J P , van Erpecum , K J , Boonstra , K , Beuers , U , Dijkgraaf , M G W & Ponsioen , C Y 2023 , ' Disease burden in primary sclerosing cholangitis in the Netherlands : A long-term follow-up study ' , Liver International , vol. 43 , no. 3 , pp. 639-648 . https://doi.org/10.1111/liv.15471 |
Schlagwörter: | disease burden / medical costs / PSC / QALY / survival / work productivity loss |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26826695 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/dedb1624-bf8a-4fb2-b3c9-456ccfcb1556 |